Cyclerion Therapeutics, Inc. (CYCN) › Shareholders' EquityCyclerion Therapeutics, Inc. (CYCN) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$8.57M2018: -$10.45M2019: $97.73M2020: $59.49M2021: $48.25M2022: $10.45M2023: $11.29M2024: $8.85M2025: $9.09M$9.09M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$9.09M+2.7%2024$8.85M-21.6%2023$11.29M+8.0%2022$10.45M-78.3%2021$48.25M-18.9%2020$59.49M-39.1%2019$97.73M+1035.7%2018-$10.45M-21.9%2017-$8.57M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share